Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1968 1
1969 1
1970 1
1971 1
1976 2
1977 1
1978 1
1979 1
1980 1
1981 1
1982 2
1983 4
1984 3
1985 3
1986 2
1987 4
1988 3
1989 4
1990 4
1991 6
1992 4
1993 5
1994 5
1995 2
1996 2
1997 3
1998 6
1999 4
2000 5
2001 4
2002 1
2003 2
2004 2
2005 3
2006 4
2007 1
2008 4
2009 5
2010 4
2011 13
2012 5
2013 4
2014 7
2015 8
2016 8
2017 11
2018 10
2019 6
2020 7
2021 8
2022 4
2023 7
2024 9
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for selby m
Search for Seby M instead (1 results)
Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression.
Lopez-Bujanda ZA, Haffner MC, Chaimowitz MG, Chowdhury N, Venturini NJ, Patel RA, Obradovic A, Hansen CS, Jacków J, Maynard JP, Sfanos KS, Abate-Shen C, Bieberich CJ, Hurley PJ, Selby MJ, Korman AJ, Christiano AM, De Marzo AM, Drake CG. Lopez-Bujanda ZA, et al. Among authors: selby mj. Nat Cancer. 2021 Aug;2(8):803-818. doi: 10.1038/s43018-021-00227-3. Epub 2021 Jul 19. Nat Cancer. 2021. PMID: 35122025 Free PMC article.
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.
Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, Sharfman WH, Stankevich E, Pons A, Salay TM, McMiller TL, Gilson MM, Wang C, Selby M, Taube JM, Anders R, Chen L, Korman AJ, Pardoll DM, Lowy I, Topalian SL. Brahmer JR, et al. Among authors: selby m. J Clin Oncol. 2010 Jul 1;28(19):3167-75. doi: 10.1200/JCO.2009.26.7609. Epub 2010 Jun 1. J Clin Oncol. 2010. PMID: 20516446 Free PMC article. Clinical Trial.
Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models.
Campbell JR, McDonald BR, Mesko PB, Siemers NO, Singh PB, Selby M, Sproul TW, Korman AJ, Vlach LM, Houser J, Sambanthamoorthy S, Lu K, Hatcher SV, Lohre J, Jain R, Lan RY. Campbell JR, et al. Among authors: selby m. Cancer Res. 2021 Jun 1;81(11):2983-2994. doi: 10.1158/0008-5472.CAN-20-3585. Epub 2021 Mar 23. Cancer Res. 2021. PMID: 33757978
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape.
Woo SR, Turnis ME, Goldberg MV, Bankoti J, Selby M, Nirschl CJ, Bettini ML, Gravano DM, Vogel P, Liu CL, Tangsombatvisit S, Grosso JF, Netto G, Smeltzer MP, Chaux A, Utz PJ, Workman CJ, Pardoll DM, Korman AJ, Drake CG, Vignali DA. Woo SR, et al. Among authors: selby m. Cancer Res. 2012 Feb 15;72(4):917-27. doi: 10.1158/0008-5472.CAN-11-1620. Epub 2011 Dec 20. Cancer Res. 2012. PMID: 22186141 Free PMC article.
In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates.
Wang C, Thudium KB, Han M, Wang XT, Huang H, Feingersh D, Garcia C, Wu Y, Kuhne M, Srinivasan M, Singh S, Wong S, Garner N, Leblanc H, Bunch RT, Blanset D, Selby MJ, Korman AJ. Wang C, et al. Among authors: selby mj. Cancer Immunol Res. 2014 Sep;2(9):846-56. doi: 10.1158/2326-6066.CIR-14-0040. Epub 2014 May 28. Cancer Immunol Res. 2014. PMID: 24872026
The use of echocardiography in the management of shock in critical care: a prospective, multi-centre, observational study.
Flower L, Waite A, Boulton A, Peck M, Akhtar W, Boyle AJ, Gudibande S, Ingram TE, Johnston B, Marsh S, Miller A, Nash A, Olusanya O, Parulekar P, Wagstaff D, Wilkinson J, Proudfoot AG; NEAT ECHO Collaborators. Flower L, et al. Intensive Care Med. 2024 Oct;50(10):1668-1680. doi: 10.1007/s00134-024-07590-6. Epub 2024 Aug 19. Intensive Care Med. 2024. PMID: 39158704
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates.
Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, Sharfman WH, Stankevich E, Pons A, Salay TM, McMiller TL, Gilson MM, Wang C, Selby M, Taube JM, Anders R, Chen L, Korman AJ, Pardoll DM, Lowy I, Topalian SL. Brahmer JR, et al. Among authors: selby m. J Clin Oncol. 2023 Feb 1;41(4):715-723. doi: 10.1200/JCO.22.02270. J Clin Oncol. 2023. PMID: 36706735 Clinical Trial.
Adenoviral vectors infect B lymphocytes in vivo.
Rice-Boucher PJ, Mendonça SA, Alvarez AB, Sturtz AJ, Lorincz R, Dmitriev IP, Kashentseva EA, Lu ZH, Romano R, Selby M, Pingale K, Curiel DT. Rice-Boucher PJ, et al. Among authors: selby m. Mol Ther. 2023 Sep 6;31(9):2600-2611. doi: 10.1016/j.ymthe.2023.07.004. Epub 2023 Jul 14. Mol Ther. 2023. PMID: 37452494 Free PMC article.
209 results